Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;29(9):3001-3009.
doi: 10.1007/s11695-019-03979-1.

Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery

Affiliations
Review

Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery

Xi Chen et al. Obes Surg. 2019 Sep.

Abstract

Metabolic surgery is an effective therapy for diabetic patients with obesity. The main mechanisms underlying the effects of metabolic surgery include food intake restriction and the accompanying reduced daily caloric intake and changes in gut hormones and bile acid. Insulin resistance and impaired β-cell function contribute to the development of type 2 diabetes. An increasing number of studies have focused on the central role of islet function in type 2 diabetes. In this article, we review the related high-quality literature and summarize the following mechanisms and principles underlying metabolic surgery in the context of islet function protection: (1) reduced glucotoxicity and chronic inflammation help facilitate better β-cell function and the preservation of β-cell mass following metabolic surgery; (2) based on the increased levels of GLP-1 and PYY after metabolic surgery, gut hormones appear to play a significant role in improving β-cell function through the GLP-1R signaling pathways; (3) the bile acid signaling pathway could affect β-cell function; and (4) the GLP-1R and bile acid signaling pathways could also cause other endocrine cells to contribute to islet function.

Keywords: Islet function; Mechanisms; Metabolic surgery; Obesity; Type 2 diabetes mellitus.

PubMed Disclaimer

References

    1. N Engl J Med. 2002 May 23;346(21):1623-30 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1042-7 - PubMed
    1. J Clin Endocrinol Metab. 2003 Jul;88(7):3177-83 - PubMed
    1. Am Surg. 2004 Jan;70(1):1-4; discussion 4-5 - PubMed
    1. Obes Res. 2004 Feb;12(2):346-50 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources